This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Shan R. Baker, MD; Richard H. Wheeler, MD; Barbara Medvec, RN

Arch Otolaryngol. 1982;108(11):703-708.

Abstract
• A totally implantable infusion pump (Infusaid) has been developed to achieve continuous drug delivery for long periods of time. The recent availability of a dualcatheter totally implantable infusion pump permits the infusion of both external carotid arteries simultaneously. This has obvious advantages for the treatment of extensive tumors of the head and neck that extend across the midline. Likewise, for the first time, unilateral local-regional disease that extends inferiorly beyond the nutrient field of the external carotid artery may be treated with intra-arterial infusion chemotherapy without the need to infuse the common carotid or innominate arteries. Unilateral infusion of the entire head and neck is accomplished by using the dual-catheter pump to infuse both the thyrocervical trunk and the external carotid artery.

(Arch Otolaryngol 1982;108:703-708)

Author Affiliations
From the Departments of Otolaryngology (Dr Baker) and Internal Medicine, Division of Hematology/Oncology (Dr Wheeler and Ms Medvec), University of Michigan, Ann Arbor.

Footnotes
Accepted for publication July 21, 1982.

Read in part before the American Society for Head and Neck Surgery, Palm Beach, Fla, May 6, 1982.

Reprint requests to Department of Otolaryngology, University of Michigan, 1405 E Ann St, Ann Arbor, MI 48109 (Dr Baker).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?